Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03699722 · ClinicalTrials.gov registry record · Phase 1
A Women-Focused PrEP Intervention
A Phase 1 study of Behavior and Behavior Mechanisms and Information Literacy, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 1
- Development phase
- 83
- Enrollment target
- 1
- Study location
NCT03699722: Completed Phase 1 study of Behavior and Behavior Mechanisms and Information Literacy, sponsored by University of Pennsylvania.
NCT03699722 is a Phase 1 study of Behavior and Behavior Mechanisms and Information Literacy that has completed, run by University of Pennsylvania. The registered enrollment target is 83 participants, below the 172-participant average among 10 other Behavior and Behavior Mechanisms trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03699722, a Phase 1 study of Behavior and Behavior Mechanisms and Information Literacy, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 83 participants
- Enrollment target
- 1
- Study location
Study Summary
Many women at high risk for acquiring HIV infection are not aware of preexposure prophylaxis (PrEP), an efficacious, self-administered, woman-controlled, HIV prevention product. The objective of this study is to evaluate the feasibility and acceptability of a theory-based intervention to promote PrEP uptake and adherence in a pilot trial among 80 women. The study will also measure intention to use PrEP and actual initiation of PrEP use. The investigators hypothesize that the intervention will be acceptable and feasible and that the intervention group will report higher levels of PrEP uptake, intention to use and adhere to PrEP, and other variables regarding PrEP uptake, comparing baseline, post-intervention and 3 month follow-up assessments.
Primary Outcome
Evaluation of fidelity behavior for each module by site coordinator after listening to audio recordings of intervention sessions using a rating form with 90% evaluation items must be 4s or 5s on a 5-point Likert scale.
Conditions Studied
Interventions
- BEHAVIORAL Education + Activities
- BEHAVIORAL Information
Study Locations (1)
Pennsylvania
- Anne Teitelman - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2018-11-03 |
| Est. Completion | 2019-11-10 |
| Phase | Phase 1 |
What the finished NCT03699722 record still lists
NCT03699722 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 83 participants, a relatively small participant target, below the 172-participant average among 10 other Behavior and Behavior Mechanisms trials with a reported enrollment target (52% lower).
The record links to 2 conditions, with Behavior and Behavior Mechanisms appearing as the primary indexed condition, and to 2 interventions - of which Education + Activities is the first listed.
NCT03699722 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03699722 about?
NCT03699722 is a clinical study titled "A Women-Focused PrEP Intervention". Many women at high risk for acquiring HIV infection are not aware of preexposure prophylaxis (PrEP), an efficacious, self-administered, woman-controlled, HIV prevention product. The objective of this study is to evaluate the feasibility and acceptability of a theory-based intervention to promote PrE...
What is the current status of trial NCT03699722?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 83 participants. The study started on 2018-11-03. Estimated completion is 2019-11-10.
What conditions does trial NCT03699722 study?
This clinical trial studies the following conditions: Behavior and Behavior Mechanisms, Information Literacy.
What interventions are being tested in trial NCT03699722?
The interventions under investigation include: Education + Activities (BEHAVIORAL), Information (BEHAVIORAL).
Who is sponsoring clinical trial NCT03699722?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03699722 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Behavior and Behavior Mechanisms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03699722's enrollment target sits among peer trials
83 7th of 10 higher than 4 of 10 other Behavior and Behavior Mechanisms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Behavior and Behavior Mechanisms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - PK Study
COMPLETED · Phase 1
-
Deimplementing CXR After CVC (DRAUP) in the ICU
RECRUITING · NA
-
Medication Adherence Program
RECRUITING · NA
-
Dental-Child Interaction Training
RECRUITING · NA
-
Learning and Living With Wildfire Smoke
ACTIVE NOT RECRUITING · NA
-
Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - Intervention Development
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI